Skip to main content
Dx & Vx Co., Ltd. logo

Dx & Vx Co., Ltd. — Investor Relations & Filings

Ticker · 180400 ISIN · KR7180400004 KO Manufacturing
Open in API
Filings indexed 474 across all filing types
Latest filing 2022-10-04 M&A Activity
Country KR South Korea
Listing KO 180400

About Dx & Vx Co., Ltd.

https://www.dxvx.com/

Dx & Vx Co., Ltd. is a bio-healthcare company specializing in diagnostics and vaccine development. Its diagnostics division offers molecular diagnostic solutions, genomics and bioinformatics services, and customized companion diagnostics (CDx), leveraging an AI-based genome analysis platform. The company's therapeutic pipeline is centered on an innovative mRNA vaccine platform designed for long-term storage at room temperature. Key development areas include vaccines for infectious diseases, immuno-therapeutic cancer vaccines, oral treatments for obesity, and therapies for eye conditions. Additionally, Dx & Vx provides contract development, manufacturing, and sales organization (CDMO/CSO) services and commercializes microbiome-based products and health supplements.

Recent filings

Filing Released Lang Actions
합병등종료보고서(자산양수도)
M&A Activity Classification · 100% confidence The document is a '합병등종료보고서' (Report on the Completion of Merger, etc.), which specifically details the finalization of an asset acquisition (자산양수도) by DXVX. It outlines the transaction details, payment completion, and the impact on the company's financial position. Since this document pertains to a corporate acquisition/merger activity, it falls under the M&A Activity category.
2022-10-04 Korean
[기재정정]주요사항보고서(타법인주식및출자증권양수결정)
M&A Activity Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) filed with the Korea Exchange regarding the acquisition of shares in another company (타법인 주식 및 출자증권 양수결정). It details the transaction, the target company's financial status, and the rationale for the acquisition. This type of regulatory filing for material corporate events, such as M&A or significant asset acquisitions, falls under the 'Regulatory Filings' (RNS) category as it is a standard disclosure requirement for listed companies in Korea.
2022-09-27 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). It details the appointment of a new outside director (Kim Han-soo) for the company DXVX. This falls under the category of announcements regarding changes in the company's board of directors or senior management.
2022-09-19 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of an Extraordinary General Meeting (EGM) held on September 19, 2022. It details the voting outcome for the appointment of an outside director. This falls under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it reports the official results of shareholder votes at a general meeting.
2022-09-19 Korean
주요사항보고서(타법인주식및출자증권양수결정)
M&A Activity Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Financial Supervisory Service/Korea Exchange regarding the acquisition of shares in another company (타법인 주식 및 출자증권 양수결정). This is a standard regulatory disclosure for material corporate events, specifically M&A-related activity. Since it details the acquisition of another entity (한국바이오팜) and is a formal regulatory filing, it falls under the M&A Activity category.
2022-09-16 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document specifically details the acquisition of convertible bonds (CB) by '디에이제일차(주)' in '디엑스앤브이엑스(주)', resulting in a significant shareholding position (12.38%). This type of filing is used to notify the market and regulators of major changes in share ownership, which corresponds to the 'Major Shareholding Notification' category.
2022-09-16 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.